On ECHEMI
Home > Drugs > Porphyria
Porphyria
Porphyria is a group of diseases caused by enzyme deficiency in the heme biosynthesis pathway. Porphyrin or its precursors such as δ-amino-r-ketovaleric acid (ALA) and porphobilinogen (PBG) are produced, the concentration is abnormally high, and it accumulates in tissues and is excreted in urine and feces. The clinical manifestations are also called porphyria, which are divided into two categories: hereditary and acquired, mainly photosensitivity dermatitis, abdominal pain and neuropsychiatric disorders. It mainly affects the nervous system and skin.
Related Drugs
Semiconductor laser therapy device
Indication: This product can improve blood rheology and microcirculation. It can improve cerebral infarction, headache, dizziness and pseudobulbar palsy in combination with drug treatment. Contraindications: Patients with malignant tumors, those who are allergic to light (such as lupus erythematosus, porphyria) and those with bradycardia. The following patients should consult a doctor before use: patients with acute diseases, infectious diseases, abnormal blood pressure, acute onset of cardiovascular and cerebrovascular diseases, skin perception disorders or skin abnormalities, and high fever patients.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.